Kumar V, Abbas AK, Aster JC. Neoplasia. In: Kumar V, Abbas AK, Aster JC, editors. Robbins and Cotran’s pathologic basis of disease. 9th ed. Philadelphia: Elsevier; 2015. p. 290–6.
Google Scholar
Setoguchi A, Sakai T, Okuda M, Minehata K, Yazawa M, Ishizaka T, et al. Aberrations of the p53 tumor suppressor gene in various tumors in dogs. Am J Vet Res. 2001;62:433–9.
CAS
PubMed
Google Scholar
Lee CH, Kim WH, Lim JH, Kang MS, Kim DY, Kweon OK. Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors. J Vet Sci. 2004;5:63–9.
PubMed
Google Scholar
Zacchetti A, van Garderen E, Rutteman GR. Immunohistochemical evaluation of p53 expression with different antibodies in malignant canine tumours with or without p53 gene mutation. Vet Comp Oncol. 2007;5:108–18.
CAS
PubMed
Google Scholar
Bongiovanni L, Mazzocchetti F, Malatesta D, Romanucci M, Ciccarelli A, Buracco P, et al. Immunohistochemical investigation of cell cycle and apoptosis regulators (Survivin, β-catenin, P53, Caspase 3) in canine appendicular osteosarcoma. BMC Vet Res. 2012;8:78.
PubMed
PubMed Central
Google Scholar
Koshino A, Goto-Koshino Y, Setoguchi A, Ohno K, Tsujimoto H. Mutation of p53 gene and its correlation with the clinical outcome in dogs with lymphoma. J Vet Intern Med. 2016;30:223–9.
CAS
PubMed
Google Scholar
Nenutil R, Smardova J, Pavlova S, Hanzelkova Z, Muller P, Fabian P, et al. Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistry. J Pathol. 2005;207:251–9.
CAS
PubMed
Google Scholar
Lodish H, Berk A, Matsudaira P, Kaiser CA, Krieger M, Scott MP, et al. Molecular cell biology. 4th ed. New York: W.H. Freeman; 2000.
Google Scholar
Bartek J, Bartkova J, Vojtesek B, Stasková Z, Lukás J, Rejthar A, et al. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene. 1991;6:1699–703.
CAS
PubMed
Google Scholar
Engeland K. Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM. Cell Death Differ. 2018;25:114–32.
CAS
PubMed
Google Scholar
Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature. 2000;408:307–10.
CAS
PubMed
Google Scholar
Rivlin N, Brosh R, Oren M, Rotter V. Mutations in the p53 tumor suppressor gene: important milestones at the various steps of tumorigenesis. Genes Cancer. 2011;2:466–74.
CAS
PubMed
PubMed Central
Google Scholar
Hu W, Feng Z, Levine AJ. The regulation of multiple p53 stress responses is mediated through MDM2. Genes Cancer. 2012;3:199–208.
CAS
PubMed
PubMed Central
Google Scholar
Cox ML, Meek DW. Phosphorylation of serine 392 in p53 is a common and integral event during p53 induction by diverse stimuli. Cell Signal. 2010;22:564–71.
CAS
PubMed
Google Scholar
Saito S, Yamaguchi H, Higashimoto Y, Chao C, Xu Y, Fornace AJ, et al. Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. J Biol Chem. 2003;278:37536–44.
CAS
PubMed
Google Scholar
Nikula KJ, Benjamin SA, Angleton GM, Saunders WJ, Lee AC. Ultraviolet radiation, solar dermatosis, and cutaneous neoplasia in beagle dogs. Radiat Res. 1992;129:11–8.
CAS
PubMed
Google Scholar
Tompkins S, Fosgate GT, Williams J, Clift S. Breed and anatomical predisposition for canine cutaneous neoplasia in South Africa during 2013. Vet Rec. 2020;186:218–26.
PubMed
Google Scholar
Yonemaru K, Sakai H, Murakami M, Kodama A, Mori T, Yanai T, et al. The significance of p53 and retinoblastoma pathways in canine hemangiosarcoma. J Vet Med Sci. 2007;69:271–8.
CAS
PubMed
Google Scholar
Chandler HL, Newkirk KM, Kusewitt DF, Dubielzig RR, Colitz CM. Immunohistochemical analysis of ocular hemangiomas and hemangiosarcomas in dogs. Vet Ophthalmol. 2009;12(2):83–90.
PubMed
Google Scholar
Wang G, Wu M, Maloneyhuss MA, Wojcik J, Durham AC, Mason NJ, et al. Actionable mutations in canine hemangiosarcoma. PLoS One. 2017. https://doi.org/10.1371/journal.pone.0188667.
Gustafson DL, Duval DL, Regan DP, Thamm DH. Canine sarcomas as a surrogate for the human disease. Pharmacol Ther. 2018;188:80–96.
CAS
PubMed
PubMed Central
Google Scholar
Kim J, Graef AJ, Dickerson EB, Modiano JF. Pathobiology of hemangiosarcoma in dogs: research advances and future perspectives. Vet Sci. 2015;2:388–405.
PubMed
PubMed Central
Google Scholar
Gamlem H, Nordstoga K, Arnesen K. Canine vascular neoplasia-a population-based clinicopathologic study of 439 tumours and tumour-like lesions in 420 dogs. APMIS Suppl. 2008;125:41–54.
Google Scholar
Sabattini S, Bettini G. An immunohistochemical analysis of canine haemangioma and haemangiosarcoma. J Comp Pathol. 2009;140:158–68.
CAS
PubMed
Google Scholar
Ward H, Fox LE, Calderwood-Mays MB, Hammer AS, Couto CG. Cutaneous hemangiosarcoma in 25 dogs: a retrospective study. J Vet Intern Med. 1994;8:345–8.
CAS
PubMed
Google Scholar
Nobrega DF, Sehaber VF, Madureira R, Bracarense APFRL. Canine cutaneous Haemangiosarcoma: biomarkers and survival. J Comp Pathol. 2019;166:87–6.
CAS
PubMed
Google Scholar
Szivek A, Burns RE, Gericota B, Affolter VK, Kent MS, Rodriguez CO Jr, et al. Clinical outcome in 94 cases of dermal haemangiosarcoma in dogs treated with surgical excision: 1993-2007*. Vet Comp Oncol. 2012;10:65–73.
CAS
PubMed
Google Scholar
Zietz C, Rössle M, Haas C, Sendelhofert A, Hirschmann A, Stürzl M, et al. MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas. Am J Pathol. 1998;153:1425–33.
CAS
PubMed
PubMed Central
Google Scholar
Italiano A, Chen CL, Thomas R, Breen M, Bonnet F, Sevenet N, et al. Alterations of p53 and PIK3CA/AKT/mTOR pathways in angiosarcomas: a pattern distinct from other sarcomas with complex genomics. Cancer. 2012;118:5878–87.
CAS
PubMed
PubMed Central
Google Scholar
Gamblin RM, Sagartz JE, Couto CG. Overexpression of p53 tumor suppressor protein in spontaneously arising neoplasms of dogs. Am J Vet Res. 1997;58:857–63.
CAS
PubMed
Google Scholar
Carvalho T, Naydan D, Nunes T, Pinto C, Peleteiro MC. Immunohistochemical evaluation of vascular urinary bladder tumors from cows with enzootic hematuria. Vet Pathol. 2009;46:211–21.
CAS
PubMed
Google Scholar
Hodgson A, Xu B, Downes MR. p53 immunohistochemistry in high-grade urothelial carcinoma of the bladder is prognostically significant. Histopathology. 2017;71:296–304.
PubMed
Google Scholar
Schlette EJ, Admirand J, Wierda W, Abruzzo L, Lin KI, O'Brien S, et al. p53 expression by immunohistochemistry is an important determinant of survival in patients with chronic lymphocytic leukemia receiving frontline chemo-immunotherapy. Leuk Lymphoma. 2009;50:1597–605.
CAS
PubMed
PubMed Central
Google Scholar
Li T, Jiang G, Chen Q, Zheng JN. Ki67 is a promising molecular target in the diagnosis of cancer (review). Mol Med Rep. 2015;11:1566–72.
CAS
PubMed
Google Scholar
Papaioannou N, Psalla D, Zavlaris M, Loukopoulos P, Tziris N, Vlemmas I. Immunohistochemical expression of dog TERT in canine testicular tumours in relation to PCNA, ki67 and p53 expression. Vet Res Commun. 2009;33:905–19.
CAS
PubMed
Google Scholar
Batinac T, Zamolo G, Jonjiæ N, Gruber F, Petrovecki M. P53 protein expression and cell proliferation in non-neoplastic and neoplastic proliferative skin diseases. Tumori. 2004;90:120–7.
PubMed
Google Scholar
Stratigos AJ, Kapranos N, Petrakou E, Anastasiadou A, Pagouni A, Christofidou E, et al. Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferation. J Eur Acad Dermatol Venereol. 2005;19:180–6.
CAS
PubMed
Google Scholar
Ansarin H, Daliri M, Soltani-Arabshahi R. Expression of p53 in aggressive and non-aggressive histologic variants of basal cell carcinoma. Eur J Dermatol. 2006;16:543–7.
PubMed
Google Scholar
Georgescu CV, Săftoiu A, Georgescu CC, Ciurea R, Ciurea T. Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma. J Gastrointestin Liver Dis. 2007;16:133–9.
PubMed
Google Scholar
Verma R, Gupta V, Singh J, Verma M, Gupta G, Gupta S, et al. Significance of p53 and ki-67 expression in prostate cancer. Urol Ann. 2015;7:488–93.
CAS
PubMed
PubMed Central
Google Scholar
Yap DB, Hsieh JK, Zhong S, Heath V, Gusterson B, Crook T, et al. Ser392 phosphorylation regulates the oncogenic function of mutant p53. Cancer Res. 2004;64:4749–54.
CAS
PubMed
Google Scholar
Minamoto T, Buschmann T, Habelhah H, Matusevich E, Tahara H, Boerresen-Dale AL, et al. Distinct pattern of p53 phosphorylation in human tumors. Oncogene. 2001;20:3341–7.
CAS
PubMed
Google Scholar
Matsumoto M, Furihata M, Kurabayashi A, Sasaguri S, Araki K, Hayashi H, et al. Prognostic significance of serine 392 phosphorylation in overexpressed p53 protein in human esophageal squamous cell carcinoma. Oncology. 2004;67:143–50.
CAS
PubMed
Google Scholar
Matsumoto M, Furihata M, Ohtsuki Y. Posttranslational phosphorylation of mutant p53 protein in tumor development. Med Mol Morphol. 2006;39:79–87.
CAS
PubMed
Google Scholar
Gillotin S, Yap D, Lu X. Mutation at Ser392 specifically sensitizes mutant p53H175 to mdm2-mediated degradation. Cell Cycle. 2010;9:1390–8.
CAS
PubMed
Google Scholar
Furihata M, Takeuchi T, Matsumoto M, Kurabayashi A, Ohtsuki Y, Terao N, et al. p53 mutation arising in Arg72 allele in the tumorigenesis and development of carcinoma of the urinary tract. Clin Cancer Res. 2002;8:1192–5.
CAS
PubMed
Google Scholar
Rocha MST, Lucci CM, Dos Santos JAM, Longo JPF, Muehlmann LA, Azevedo RB. Photodynamic therapy for cutaneous hemangiosarcoma in dogs. Photodiagn Photodyn Ther. 2019;27:39–43.
CAS
Google Scholar
Heinzelmann-Schwarz V, Fedier A, Hornung R, Walt H, Haller U, Fink D. Role of p53 and ATM in photodynamic therapy-induced apoptosis. Lasers Surg Med. 2003;33(3):182–9.
PubMed
Google Scholar
Shin SJ, Lesser M, Rosen PP. Hemangiomas and angiosarcomas of the breast: diagnostic utility of cell cycle markers with emphasis on Ki-67. Arch Pathol Lab Med. 2007;131:538–44.
PubMed
Google Scholar
Millanta F, Fratini F, Corazza M, Castagnaro M, Zappulli V, Poli A. Proliferation activity in oral and cutaneous canine melanocytic tumours: correlation with histological parameters, location, and clinical behaviour. Res Vet Sci. 2002;73:45–51.
CAS
PubMed
Google Scholar
Schultheiss PC. A retrospective study of visceral and nonvisceral hemangiosarcoma and hemangiomas in domestic animals. J Vet Diagn Investig. 2004;16:522–6.
Google Scholar
Ogilvie GK, Powers BE, Mallinckrodt CH, Withrow SJ. Surgery and doxorubicin in dogs with hemangiosarcoma. J Vet Intern Med. 1996;10:379–84.
CAS
PubMed
Google Scholar
Koenig A, Blanco SR, Fosmire S, Wojcieszyn J, Modiano JF. Expression and significance of p53, Rb, p21/waf-1, p16/ink-4a, and PTEN tumor suppressors in canine melanoma. Vet Pathol. 2002;39:458–72.
CAS
PubMed
Google Scholar